Imfinzi (durvalumab) - AstraZeneca
Yervoy (ipilimumab) - BMS
CP-506 - Convert Pharma
Tecentriq (atezolizumab) - Roche
Opdivo (nivolumab) - Ono Pharma, BMS
carboplatin - Generic mfg.
Bavencio (avelumab) - EMD Serono
Keytruda (pembrolizumab) - Merck (MSD)
Libtayo (cemiplimab-rwlc) - Regeneron
http://clinicaltrials.gov/ct2/show/NCT04954599
 
Oct 8, 2025
 
Next